Importantly, we discovered that TLR8 signaling in tumor cells can block the induction of senescence in naïve and tumor-specific effector T cells and reverse their suppressive effects in vitro and in vivo, resulting in enhanced anti-tumor immunity. This evidence concerns the gene TLR8 and neoplasm.